Invention Publication
- Patent Title: MONOCYTES INDUCING ANTIGEN-SPECIFIC TOLERANCE, ENGINEERED MONOCYTES, AND METHOD OF USE THEREOF
-
Application No.: US17958041Application Date: 2022-09-30
-
Publication No.: US20230263888A1Publication Date: 2023-08-24
- Inventor: Daniel GETTS
- Applicant: Myeloid Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Myeloid Therapeutics, Inc.
- Current Assignee: Myeloid Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K38/18 ; A61K38/20 ; A61K38/17 ; A61K39/39 ; A61K31/155 ; A61P37/06
Abstract:
Methods and compositions for treating autoimmune diseases and conditions using engineered myeloid cells.
Information query
